These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6978405)

  • 1. Effect of whole-body hyperthermia on delayed cutaneous hypersensitivity to oxazolone in mice.
    Roszkowski W; Roszkowski K; Wrembel K; Szmigielski S; Pulverer G; Jeljaszewicz J
    J Clin Lab Immunol; 1981 Nov; 6(3):257-61. PubMed ID: 6978405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed cutaneous hypersensitivity to oxazolone in mice with tumors.
    Hemsworth GR; Wolff JS; Kraska AR; Jensen KE
    Cancer Res; 1978 Apr; 38(4):907-10. PubMed ID: 639044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of delayed-type hypersensitivity to oxazolone in whole-body-irradiated mice and protection by WR-2721.
    Srinivasan V; Weiss JF
    Radiat Res; 1984 Jun; 98(3):438-44. PubMed ID: 6328568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine lymph node antigen presenting cells are the main source of interleukin-6 in the initiation of delayed-type hypersensitivity.
    Ulrich P; Vohr HW
    Eur Cytokine Netw; 1996 Sep; 7(3):401-7. PubMed ID: 8954184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphology and cytodynamics of oxazolone-induced cellular immune response].
    Kalász V; Németh A
    Morphol Igazsagugyi Orv Sz; 1981 Jul; 21(3):161-7. PubMed ID: 7266549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cell-mediated immunity in the mouse: circumstantial evidence for highly immunogenic antigen in the regional lymph nodes following skin painting with contact sensitizing agents.
    Asherson GL; Mayhew B
    Isr J Med Sci; 1976; 12(4-5):454-67. PubMed ID: 1084883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T suppressor cells and suppressor factor which act at the efferent stage of the contact sensitivity skin reaction: their production by mice injected with water-soluble, chemically reactive derivatives of oxazolone and picryl chloride.
    Asherson GL; Zembala M
    Immunology; 1980 Dec; 41(4):1005-13. PubMed ID: 6450725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of whole-body microwave hyperthermia on delayed cutaneous hypersensitivity in tumor-bearing mice.
    Roszkowski W; Wrembel JM; Roszkowski K; Janiak M; Szmigielski S
    J Cancer Res Clin Oncol; 1980; 97(1):23-9. PubMed ID: 7400204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of efferent lymph cells from nodes stimulated with oxazolone.
    Hall JG; Hopkins J; Reynolds J
    Immunology; 1980 Feb; 39(2):141-9. PubMed ID: 7380464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological competence in Snell-Bagg pituitary dwarf mice: response to the contact-sensitizing agent oxazolone.
    Schneider GB
    Am J Anat; 1976 Mar; 145(3):371-93. PubMed ID: 1266774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired cutaneous immune responses in Thy-1-deficient mice.
    Beissert S; He HT; Hueber AO; Lellouch AC; Metze D; Mehling A; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1998 Nov; 161(10):5296-302. PubMed ID: 9820502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic cells in the regional lymph nodes after painting with the contact sensitizers picryl chloride and oxazolone: evidence for the presence of IgM antibody on their surface.
    Asherson GL; Colizzi V; Watkins MC
    Immunology; 1983 Mar; 48(3):561-9. PubMed ID: 6826205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The function of high endothelial venules in mouse lymph nodes stimulated by oxazolone.
    Mebius RE; Brevé J; Duijvestijn AM; Kraal G
    Immunology; 1990 Nov; 71(3):423-7. PubMed ID: 2269478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control of the proliferative response to oxazolone in H-2 congenic and recombinant strains of mice.
    Bösze Z; Fachet J
    Immunology; 1979 Dec; 38(4):749-55. PubMed ID: 521059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed hypersensitivity in mast-cell-deficient mice.
    Thomas WR; Schrader JW
    J Immunol; 1983 Jun; 130(6):2565-7. PubMed ID: 6602168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular dynamics in the draining lymph nodes during sensitization and elicitation phases of contact hypersensitivity.
    Larsen JM; Geisler C; Nielsen MW; Boding L; Von Essen M; Hansen AK; Skov L; Bonefeld CM
    Contact Dermatitis; 2007 Nov; 57(5):300-8. PubMed ID: 17937744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation.
    Moodycliffe AM; Bucana CD; Kripke ML; Norval M; Ullrich SE
    J Immunol; 1996 Oct; 157(7):2891-9. PubMed ID: 8816394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
    Shimizu T; Abe R; Nishihira J; Shibaki A; Watanabe H; Nakayama T; Taniguchi M; Ishibashi T; Shimizu H
    Eur J Immunol; 2003 Jun; 33(6):1478-87. PubMed ID: 12778465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of the immune response. I. Depression of DNA synthesis by immune lymph node cells.
    Asherson GL; Wood PJ; Mayhew B
    Immunology; 1975 Dec; 29(6):1057-65. PubMed ID: 1193682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between interleukin-6 production by contact allergen-activated draining lymph node cells and lymphoproliferative activity.
    Lappin MB; Dearman RJ; Norval M; Kimber I
    Am J Contact Dermat; 1998 Mar; 9(1):34-9. PubMed ID: 9471985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.